• Big Pharma will Benefit from New ADME LIMS

Laboratory products

Big Pharma will Benefit from New ADME LIMS

A ‘Top 10’ pharmaceutical company is one of the first to implement Debra 5.7.7 - the latest release of LabLogic Systems’ LIMS for drug metabolism studies. Recent developments in the software, in particular the new Protein Binding and Pooling modules, will bring efficiency improvements to the company’s research centres in Switzerland and the USA, which have been using Debra 5.4 since 2002.

For the last few years the USA research centre has also been using LabLogic’s Laura 4 radiochromatography software package - but with the disadvantage that all data had to be stored on 20 stand-alone workstations. As part of the upgrade project, a centralised database is being introduced so that data and methods can be shared easily between HPLC workstations and data can be imported into Debra. The company opted to use LabLogic’s validation services to implement Debra 5.7.7, just as it did for the 5.4 release that it has used until now.


Digital Edition

Lab Asia 31.6 Dec 2024

December 2024

Chromatography Articles - Sustainable chromatography: Embracing software for greener methods Mass Spectrometry & Spectroscopy Articles - Solving industry challenges for phosphorus containi...

View all digital editions

Events

Smart Factory Expo 2025

Jan 22 2025 Tokyo, Japan

Instrumentation Live

Jan 22 2025 Birmingham, UK

SLAS 2025

Jan 25 2025 San Diego, CA, USA

Arab Health

Jan 27 2025 Dubai, UAE

Nano Tech 2025

Jan 29 2025 Tokyo, Japan

View all events